Evaluating Skin Appearance Following 5-Flourouracil Cream for Treatment of Actinic Keratosis and the Effects of Topical Agents
| Status: | Recruiting |
|---|---|
| Conditions: | Dermatology |
| Therapuetic Areas: | Dermatology / Plastic Surgery |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 11/3/2017 |
| Start Date: | October 10, 2017 |
| End Date: | October 10, 2019 |
This proposed project will be an open-label, split face, randomized controlled pilot study.
Up to 60 patients with diffuse facial actinic keratosis will be enrolled in the study. The
purpose of this study is to understand the change in skin appearance throughout 5-FU
treatment course and to examine whether a topical corticosteroid and moisturizer can decrease
severity and duration of skin inflammation after 5-FU treatment course.
Up to 60 patients with diffuse facial actinic keratosis will be enrolled in the study. The
purpose of this study is to understand the change in skin appearance throughout 5-FU
treatment course and to examine whether a topical corticosteroid and moisturizer can decrease
severity and duration of skin inflammation after 5-FU treatment course.
The purpose of this study to understand the change in skin appearance during and after the
course of 5-FU cream in patients with AK, and compare how the appearance of skin inflammation
changes with the use of topical corticosteroids and moisturizers.
course of 5-FU cream in patients with AK, and compare how the appearance of skin inflammation
changes with the use of topical corticosteroids and moisturizers.
Inclusion Criteria:
- Male and female, at least 18 years of age
- Subject must have a diagnosis of actinic keratosis (at least 5 lesions on each side of
the face)
- Able to comprehend and read the English language
Exclusion Criteria:
- Subjects who do not fit the inclusion criteria
- Concurrently have other inflammatory skin conditions.
- Prior known allergy to any components to of 5FU cream, topical steroid ointment or
vaseline.
• Subject who, in the opinion of the investigator, will be uncooperative or unable to
comply with study procedures (i.e.: compliant with using 5-FU cream, topical
corticosteroid or moisturizers
- Those that are prisoners or cognitively impaired.
We found this trial at
1
site
7005 North Oracle Road
Tucson, Arizona 85704
Tucson, Arizona 85704
Principal Investigator: Vivian Y Shi, MD
Phone: 520-694-9075
Click here to add this to my saved trials
